To further establish the contributions of CD8+ T and NK cells in DSF/Cu and anti-PD-1-mediated tumor growth inhibition, we depleted these cells in LLC-tumor bearing mice using specific antibodies (Fig. 6I). This evidence concerns the gene CD8A and neoplasm.